Semanteon Capital Management LP Makes New Investment in Lam Research Corporation $LRCX

Semanteon Capital Management LP purchased a new stake in Lam Research Corporation (NASDAQ:LRCX) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 4,242 shares of the semiconductor company’s stock, valued at approximately $568,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Howard Hughes Medical Institute purchased a new stake in Lam Research in the second quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC purchased a new position in shares of Lam Research in the second quarter valued at approximately $29,000. Delos Wealth Advisors LLC acquired a new position in shares of Lam Research in the second quarter valued at approximately $30,000. Bank of Jackson Hole Trust grew its stake in shares of Lam Research by 111.1% in the second quarter. Bank of Jackson Hole Trust now owns 380 shares of the semiconductor company’s stock worth $37,000 after acquiring an additional 200 shares in the last quarter. Finally, Barnes Dennig Private Wealth Management LLC purchased a new stake in shares of Lam Research during the second quarter worth $38,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Price Performance

Shares of LRCX opened at $244.92 on Friday. The firm has a market capitalization of $305.85 billion, a PE ratio of 50.19, a P/E/G ratio of 2.63 and a beta of 1.78. The stock’s 50 day moving average is $209.11 and its two-hundred day moving average is $160.30. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $251.87. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The company’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be paid a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio (DPR) is presently 21.31%.

Analyst Ratings Changes

Several brokerages have weighed in on LRCX. Cantor Fitzgerald restated an “overweight” rating and set a $320.00 price target (up previously from $265.00) on shares of Lam Research in a report on Thursday, January 29th. Bank of America upped their target price on shares of Lam Research from $195.00 to $245.00 and gave the stock a “buy” rating in a research note on Tuesday, January 13th. Wells Fargo & Company lifted their price target on shares of Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Jefferies Financial Group restated a “buy” rating and issued a $200.00 price target (up from $175.00) on shares of Lam Research in a research note on Monday, December 15th. Finally, Wall Street Zen downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $244.88.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: TD Cowen raised its price target sharply to $290 (from $170) and kept a Buy rating, highlighting the large 2026 WFE market opportunity that benefits Lam. Is Lam Research (LRCX) One of the Best Growth Stocks to Buy for the Next 20 Years?
• Positive Sentiment: BofA’s Vivek Arya named Lam his top semiconductor-equipment pick, citing a projected ~$135B industry spending surge in 2026 as AI demand forces multi-year factory investment — a direct tailwind for Lam’s tools. Lam Research Named Top Semiconductor Pick As AI-Driven Manufacturing Supercycle Shifts Into High Gear
• Positive Sentiment: Lam’s Boise expansion strengthens its operational ties with Micron and positions the company to capture increased demand for AI memory production equipment. This local expansion is being read as evidence of customers ramping capacity. Lam Research Boise Expansion Deepens Micron Ties In AI Memory Cycle
• Positive Sentiment: Multiple bullish write-ups argue Lam has durable growth attributes that could drive strong multi-year returns, reinforcing investor conviction around the AI/memory-driven cycle. 3 Reasons Growth Investors Will Love Lam Research (LRCX) 3 Reasons Growth Investors Will Love Lam Research (LRCX) Is Lam Research (LRCX) One of the Best Growth Stocks to Buy for the Next 20 Years?
• Neutral Sentiment: A report about Japan’s Toto (a supplier to chip-equipment makers) and activist interest may signal broader supply‑chain positioning for chip-equipment suppliers, but it’s peripheral to Lam’s core demand drivers. This Toilet Stock Is Surging as an AI Bet. An Activist Sees More Gains.
• Neutral Sentiment: Two short-interest data entries in the feed show zero or inconsistent values (0 shares / NaN), which appears to be a reporting/data issue rather than a meaningful change in betting against the stock. Monitor reliable short-interest releases for any real pressure.
• Neutral Sentiment: Articles discussing the evolving Lam narrative compile the above themes (upgraded targets, expansion, AI cycle) — useful context but largely reiterative rather than new catalysts. How The Narrative Around Lam Research (LRCX) Is Evolving With New Forecasts And Expansion Moves

Insiders Place Their Bets

In other news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the transaction, the director owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.31% of the company’s stock.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.